First Human Case of Shamonda Virus Leads to Fatality in France
A patient with a serious illness becomes the first known human case of the Shamonda virus, resulting in death, as investigations continue.
The first human case of Shamonda virus has been reported in France, leading to a fatality.
The patient was immunocompromised and had been undergoing treatment for a serious illness.
No public health risk has been identified, and investigations into human transmission are ongoing.
In a significant health development, France has reported the first known human case of the Shamonda virus, resulting in the death of an immunocompromised patient. This case, which occurred in early October, has raised concerns but authorities have stated that there is currently no identified risk to public health.
The patient, whose identity remains undisclosed, was already vulnerable due to ongoing treatment for a serious illness. French health and agriculture ministries confirmed that the virus, previously detected only in livestock, is transmitted by midges, small flying insects. The Shamonda virus was first isolated from cattle in Nigeria in 1965 and has since been identified in various regions across Africa, Asia, and Europe.
Symptoms of Shamonda virus in animals include fever, diarrhea, reduced milk production, and reproductive issues such as miscarriages. Neurological symptoms have also been reported, albeit less frequently. The World Organisation for Animal Health (WOAH) has noted that the virus primarily affects livestock, including cattle, sheep, goats, horses, and alpacas.
The World Health Organization (WHO) has emphasized the need for further research to understand the transmission of the virus to humans. The patient had been in an area where the virus was circulating among animals, and the presence of Culicoides midges, known to transmit certain animal viruses, was confirmed. The WHO is collaborating with French authorities to gather information on the infection route and assess any potential public health risks.
Currently, there are no vaccines available for the Shamonda virus, according to WOAH. The ongoing investigations aim to clarify the circumstances surrounding the patient's infection and to ensure public safety as health officials monitor the situation closely.
